Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B.
Gut
; 70(11): 2172-2182, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-33239344
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Cost-Benefit Analysis
/
Quality-Adjusted Life Years
/
Hepatitis B, Chronic
Type of study:
Health_economic_evaluation
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Gut
Year:
2021
Type:
Article